« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 122, Issue 6
, Pages 1169-1177.e16
, December 2008
Hypomorphic nuclear factor-κB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity
References
- Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes. Hum Mol Genet. 2001;10:2557–2567
- . Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006;25:6680–6684
- A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet. 2000;67:1555–1562
- X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet. 2001;27:277–285
- . Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol. 2001;2:223–228
- . A20 inhibits tumor necrosis factor (TNF) α-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells. Mol Cell Biol. 2002;22:6034–6045
- . Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr Protoc Immunol. 2001;31:14–29
- . NKp30 ligation induces rapid activation of the canonical NF-κB pathway in NK cells. J Immunol. 2007;179:7385–7396
- . Dimerization of the I kappa B kinase-binding domain of NEMO is required for tumor necrosis factor alpha-induced NF-kappa B activity. Mol Cell Biol. 2006;26:9209–9219
- The trimerization domain of NEMO is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains. J Biol Chem. 2004;279:27861–27869
- . Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kB activation. [corrected] Nat Cell Biol. 2006;8:398–406
- . A new mutation in exon 7 of NEMO gene: late skewed X-chromosome inactivation in an incontinentia pigmenti female patient with immunodeficiency. Hum Genet. 2005;118:458–465
- . Female patient showing hypohidrotic ectodermal dysplasia and immunodeficiency (HED-ID). Am J Hum Genet. 2001;69:664–666
- Transient hemophagocytosis with deficient cellular cytotoxicity, monoclonal immunoglobulin M gammopathy, increased T-cell numbers, and hypomorphic NEMO mutation. Pediatrics. 2006;117:e1049–e1056
- Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics. 2002;109:e97
- Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection. Am J Med Genet. 2001;99:172–177
- X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival. Blood. 2004;103:4565–4572
- Novel splicing mutation in the NEMO (IKK-g) gene with severe immunodeficiency and heterogeneity of X-chromosome inactivation. Am J Med Genet A. 2006;140:31–39
- Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature. 2000;405:466–472
- Ectodermal dysplasia with immunodeficiency and lymphedema, but not osteopetrosis, is associated with a unique NF-κB essential modulator (NEMO) mutation. Clin Immunol. 2005;116:300–301
- . Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation. Immunol Rev. 2005;203:21–37
- Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia. J Allergy Clin Immunol. 2004;114:1456–1462
- . The presentation and natural history of immunodeficiency caused by nuclear factor κB essential modulator mutation. J Allergy Clin Immunol. 2004;113:725–733
- IKBKG (nuclear factor-κB essential modulator) mutation can be associated with opportunistic infection without impairing TLR function. J Allergy Clin Immunol. 2007;121:976–982
- Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest. 2002;109:1501–1509
- Characteristics of mycobacterial infection in patients with immunodeficiency and nuclear factor-kappaB essential modulator mutation, with or without ectodermal dysplasia. J Am Acad Dermatol. 2004;51:718–722
- X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med. 2006;203:1745–1759
- Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia. J Allergy Clin Immunol. 2004;114:650–656
- Impaired dendritic-cell function in ectodermal dysplasia with immune deficiency is linked to defective NEMO ubiquitination. Blood. 2006;108:2324–2331
- . Innate immunity–cross-talk with adaptive immunity through pattern recognition receptors and cytokines. Curr Opin Immunol. 2007;19:1–3
- . Expression and function of Toll-like receptors in T lymphocytes. Curr Opin Immunol. 2007;19:39–45
- . Anhidrotic ectodermal dysplasia associated with specific antibody deficiency. Eur J Pediatr. 1996;155:146–147
- . Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation. J Mol Biol. 2008;377:1419–1432
- Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007;446:557–561
- Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature. 2007;446:552–556
Supported by National Institutes of Health (NIH) AI079731 (J.S.O.), US Immunodeficiency Network Grant NIH N01 AI-22070 (J.S.O., M.J.M.), NIH HL080612 (M.J.M), the Pennsylvania Department of Health (J.S.O.; the Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusions from this study), a career development award from the American Academy of Allergy, Asthma & Immunology (J.S.O.), NIH 5T32CA009140-33 (E.P.H.), and the Penn Center for Clinical Immunology Jackson-Wade Fellowship (E.P.H.)
Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.
PII: S0091-6749(08)01545-5
doi: 10.1016/j.jaci.2008.08.018
© 2008 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 122, Issue 6
, Pages 1169-1177.e16
, December 2008
